Antifungal resistance represents a major clinical challenge to clinicians responsible for
treating invasive fungal infections due to the limited arsenal of systemically available …

Candida species are one of the commonest causes of vaginitis in healthy women of
reproductive age. Vulvovaginal candidiasis (VVC) is characterized by vulvovaginal itching …

Objectives Knowledge of contemporary epidemiology of candidaemia is essential. We
aimed to identify changes since 2004 in incidence, species epidemiology and antifungal …

Clinically available antifungals for the treatment of invasive fungal infections primarily target
either ergosterol in the fungal cell membrane or 1, 3-β-D-glucan in the fungal cell wall …

Antifungal resistance to Candida pathogens increases morbidity and mortality of
immunosuppressive patients, an emerging crisis worldwide. Understanding the Candida …

Candida parapsilosis is becoming a predominant non-albicans cause of invasive
candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis …

Bloodstream infections caused by Candida species are of increasing importance and
associated with significant mortality. We performed a multi-centre prospective observational …

Data on the epidemiology of invasive candidiasis (IC) and the antifungal susceptibility of
Candida isolates in China are still limited. Here we report on surveillance for IC from the …

In the Asia-Pacific region, Candida albicans is the predominant Candida species causing
invasive candidiasis/candidemia in Australia, Japan, Korea, Hong Kong, Malaysia …

Fungal infections have aroused much interest over the last years because of their
involvement in several human diseases. Immunocompromission due to transplant-related …